Jump to ContentJump to Main Navigation
The Politics of PrecautionRegulating Health, Safety, and Environmental Risks in Europe and the United States$
Users without a subscription are not able to see the full content.

David Vogel

Print publication date: 2012

Print ISBN-13: 9780691124162

Published to Princeton Scholarship Online: October 2017

DOI: 10.23943/princeton/9780691124162.001.0001

Show Summary Details
Page of

PRINTED FROM PRINCETON SCHOLARSHIP ONLINE (www.princeton.universitypressscholarship.com). (c) Copyright Princeton University Press, 2017. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a monograph in HSO for personal use (for details see http://www.universitypressscholarship.com/page/privacy-policy).date: 12 December 2017

Consumer Safety

Consumer Safety

Chapter:
(p.189) Chapter Six Consumer Safety
Source:
The Politics of Precaution
Author(s):

David Vogel

Publisher:
Princeton University Press
DOI:10.23943/princeton/9780691124162.003.0006

This chapter analyzes European and American policies toward a range of consumer safety risks; including drugs, children's products, and cosmetics. It shows how European and American risk regulations have converged, though the dynamics through which this occurred differed substantially. Pharmaceutical regulation constitutes the most important exception to the broader pattern of increased transatlantic regulatory policy divergence. What makes this area of regulatory policy distinctive is that its political salience increased in the United States but not in Europe. Pharmaceutical regulation also represents an important exception to the dominant pattern of transatlantic regulatory policy diffusion. In this case, European regulatory policies did affect those of the United States, first by highlighting the transatlantic drug lag, and more recently by American decisions to adopt some European practices to expedite drug approvals.

Keywords:   consumer safety, drugs, cosmetics, risk regulations, pharmaceutical regulation, political salience, drug lag, safety risks

Princeton Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.